Hemogenyx Pharmaceuticals' market value is the price at which a share of Hemogenyx Pharmaceuticals trades on a public exchange. It measures the collective expectations of Hemogenyx Pharmaceuticals Plc investors about its performance. Hemogenyx Pharmaceuticals is trading at 1.24 as of the 7th of January 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.24. With this module, you can estimate the performance of a buy and hold strategy of Hemogenyx Pharmaceuticals Plc and determine expected loss or profit from investing in Hemogenyx Pharmaceuticals over a given investment horizon. Check out Hemogenyx Pharmaceuticals Correlation, Hemogenyx Pharmaceuticals Volatility and Hemogenyx Pharmaceuticals Alpha and Beta module to complement your research on Hemogenyx Pharmaceuticals.
Please note, there is a significant difference between Hemogenyx Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hemogenyx Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hemogenyx Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Hemogenyx Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hemogenyx Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hemogenyx Pharmaceuticals.
0.00
11/08/2024
No Change 0.00
0.0
In 2 months and 2 days
01/07/2025
0.00
If you would invest 0.00 in Hemogenyx Pharmaceuticals on November 8, 2024 and sell it all today you would earn a total of 0.00 from holding Hemogenyx Pharmaceuticals Plc or generate 0.0% return on investment in Hemogenyx Pharmaceuticals over 60 days. Hemogenyx Pharmaceuticals is related to or competes with ProMIS Neurosciences, Fennec Pharmaceuticals, Inhibrx, Celcuity LLC, Enliven Therapeutics, Genelux Common, and Dyadic International. Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and com... More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hemogenyx Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hemogenyx Pharmaceuticals Plc upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hemogenyx Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hemogenyx Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Hemogenyx Pharmaceuticals historical prices to predict the future Hemogenyx Pharmaceuticals' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Hemogenyx Pharmaceuticals. Your research has to be compared to or analyzed against Hemogenyx Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Hemogenyx Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Hemogenyx Pharmaceuticals.
Hemogenyx Pharmaceuticals Backtested Returns
Hemogenyx Pharmaceuticals is out of control given 3 months investment horizon. Hemogenyx Pharmaceuticals holds Efficiency (Sharpe) Ratio of 0.11, which attests that the entity had a 0.11% return per unit of risk over the last 3 months. We have analyze and collected data for sixteen different technical indicators, which can help you to evaluate if expected returns of 14.52% are justified by taking the suggested risk. Use Hemogenyx Pharmaceuticals Plc Market Risk Adjusted Performance of (2.09), standard deviation of 127.84, and Risk Adjusted Performance of 0.1019 to evaluate company specific risk that cannot be diversified away. Hemogenyx Pharmaceuticals holds a performance score of 8 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -6.91, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Hemogenyx Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Hemogenyx Pharmaceuticals is expected to outperform it. Use Hemogenyx Pharmaceuticals Plc variance, skewness, as well as the relationship between the Skewness and day typical price , to analyze future returns on Hemogenyx Pharmaceuticals Plc.
Auto-correlation
0.00
No correlation between past and present
Hemogenyx Pharmaceuticals Plc has no correlation between past and present. Overlapping area represents the amount of predictability between Hemogenyx Pharmaceuticals time series from 8th of November 2024 to 8th of December 2024 and 8th of December 2024 to 7th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hemogenyx Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current Hemogenyx Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
0.0
Spearman Rank Test
0.82
Residual Average
0.0
Price Variance
0.0
Hemogenyx Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Hemogenyx Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hemogenyx Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Hemogenyx Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Hemogenyx Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Hemogenyx Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hemogenyx Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hemogenyx Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hemogenyx Pharmaceuticals pink sheet over time.
Current vs Lagged Prices
Timeline
Hemogenyx Pharmaceuticals Lagged Returns
When evaluating Hemogenyx Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hemogenyx Pharmaceuticals pink sheet have on its future price. Hemogenyx Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hemogenyx Pharmaceuticals autocorrelation shows the relationship between Hemogenyx Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Hemogenyx Pharmaceuticals Plc.
Other Information on Investing in Hemogenyx Pink Sheet
Hemogenyx Pharmaceuticals financial ratios help investors to determine whether Hemogenyx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemogenyx with respect to the benefits of owning Hemogenyx Pharmaceuticals security.